Study finds no short-term heart risks from ADHD drugs in adults

02/26/2013 | DailyRx.com

Researchers looked at the records of nearly 300,000 adult patients with attention-deficit/hyperactivity disorder and found that those who took amphetamines or atomoxetine were not more likely to develop stroke, heart attack or other serious heart problems during the first few months of treatment than those who didn't take the drugs. The study appeared in the journal PLoS One.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ